Gen-Probe Incorporated
(NASDAQ:GPRO)|
41.27 -0.20 (-0.48%) 12:45ET Delayed |
|
|
|
- Compare GPRO with:
- View: Line | Candlestick
Company Profile
Gen-Probe Incorporated
10210 Genetic Center Drive
San Diego, CA 92121
United States - Map
Phone: (858) 410-8000
Fax: (858) 410-8000
Website: www.gen-probe.com
State of incorporation: Delaware
CEO: Henry L. Nordhoff
Employees: 987
Sector: Services
Industry Group: Diversified Services
Industry: Research Services
Engage in clinical diagnosis of human diseases
The Company is engaged in the development, manufacture and marketing of rapid, accurate and cost-effective nucleic acid probe-based products used for the clinical diagnosis of human diseases and for screening donated human blood.
Recent news for GPRO
-
Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference
PR Newswire - 19 hours ago
-
PowerRatings Weekly Recap: GPRO, RGLD, TEVA, CEPH
TradingMarkets.com - Jan 02 at 10:47 ET
-
FDA approves new HIV blood test from Roche
AP - Dec 30 2008 at 5:49 ET
-
Monday PowerRating Upgrades: GPRO,PGN RGLD
TradingMarkets.com - Dec 29 2008 at 10:36 ET
-
8 More Investment Candidates from Forbes' 'Best Small Companies' List
Seeking Alpha - Dec 23 2008 at 5:11 ET
-
Sector Snap: Med Tech stocks slip on target cuts
AP - Dec 15 2008 at 11:15 ET
-
Gen-Probe to Webcast Presentation at the 20th Annual Piper Jaffray Health Care Conference
PR Newswire - Nov 25 2008 at 4:03 ET
-
PR Newswire - Nov 21 2008 at 3:00 ET
-
Coverage initiated on Gen-Probe by Needham
Briefing.com - Nov 20 2008 at 12:51 ET
-
TheStreet.com - Nov 19 2008 at 5:11 ET